Article
European Alzheimer's experts unconvinced by new Eisai, Biogen drug
Rating:
0.0
Views:
52
Likes:
1
Library:
1
Alzheimer's disease experts in Europe weighing potential use of a new drug from Eisai and Biogen say its ability to slow cognitive decline may not outweigh its health risks, or be worth the toll on scarce healthcare resources.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value